Trump National Doral
Miami, Florida

This three-day conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advances registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties are encouraged to attend.

Topics in breast cancer, gastrointestinal (GI) malignancies, head and neck cancers, hematological malignancies (i.e., multiple myeloma, CLL, CML, and Non-Hodgkin’s lymphoma) genito-urinary cancers (GU), brain tumors, malignant melanoma, and non-small cell lung cancer (NSCLC) will be presented. The areas of focus for this conference will include the review of current standards of care in the treatment of all malignancies and new developments in cancer care. There will be an emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. Presentations from latest national and international meetings will be reviewed and guidelines of cancer care will be emphasized.

 
For conference details, to register to the event and make your hotel reservation, visit 2021 MCM

How the Masters Treat Cancer

Loews Vanderbilt Hotel | Nashville, Tennessee

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

For complete conference details, hotel and registration information please visit: MLS Nashville

The Roosevelt New Orleans Hotel
New Orleans, Louisiana

This Master Lecture Series (MLS) will provide current, practical information on the management of immunotherapy and target therapies. Novel agents and strategies will be discussed with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), Melanoma, Lung (RET/MET/ VEGFR2) & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

This Master Lecture Series is a one-day program designed for medical oncologists, radiation oncologists, surgical oncologists, advanced registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties will also be in attendance.

Complete conference details, hotel and registration information please visit: MLS New Orleans.

The Langham Huntington Hotel
Pasadena, CA

This conference will bring together top oncologists for a comprehensive review and updated data in hematology, medical oncology, gynecology malignancies, immunotherapy, supportive care, healthcare policies and novel technologies in cancer management. This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances.

Complete conference information coming soon.

The Kimpton Sawyer Hotel
Sacramento, CA

As a result of prior course participant evaluations and needs assessment surveys, the need for cutting edge information on prognostic markers and appropriate application of novel therapies has been identified. This year’s conference will specifically address these needs in the common malignancies identified by past participants as essential to their practice, including solid and hematologic cancers. The timing of this meeting in the fall allows for the latest findings in clinical cancer research from major hematology and oncology conferences to be presented and discussed. This educational activity also meets a unique need for the Northern California Sacramento Valley to provide a group of networked and collaborating oncologists a forum to discuss the most recent developments in oncology care in the context of local treatment approaches, patient populations, and open clinical trials.

For complete conference details, hotel and registration information please visit: Advances In Oncology

The Roosevelt New Orleans Hotel

New Orleans, LA

Conference information, registration and hotel reservation information coming soon.